FDA Guidance Document Concerning Use of Pilot Manufacturing Facilities for the Development and Manufacture of Biological Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
July 11, 1995
July 26, 2024
d98f4363-07c5-4cc7-a8ff-82c072cb88b2
Related Documents
Interacting with the FDA on Complex Innovative Trial Designs for Drugs and Biological Products: Guidance for Industry
Guidance DocumentDecember 16, 2020Center for Biologics Evaluation and Research
Development of Monoclonal Antibody Products Targeting SARS-CoV-2 for Emergency Use Authorization
Guidance DocumentDecember 21, 2023Center for Drug Evaluation and Research
Points to Consider in the Manufacture and Testing of Monoclonal Antibody Products for Human Use
Guidance DocumentFebruary 28, 1997Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox